DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Galmed Pharmaceuticals Ltd. (GLMD)
« Back to company indexGLMD Chatter Timeline
Stock Ticker for GLMD
Most Active Tweeters for GLMD
| User | Tweets |
|---|---|
| @AmericanBanking | 6 |
| @Miljenkoz | 4 |
| @techwhitepapers | 4 |
| @ZolmaxNews | 4 |
| @ConsumerFeed | 4 |
Recent Tweets for GLMD
 |
@SiteFocusHQ $GLMD Earnings Intelligence Analysis of recent earnings identified Galmed Pharmaceuticals Ltd. (GLMD) business focu… https://t.co/aU0CXnNnGA November 10th 2019, 11:11am |
 |
@BlueBioNow $GLMD Always buy on Fear ..?????????????? -3.66 % change recently https://t.co/NBRHpPSfCE November 10th 2019, 10:11am |
 |
@SeekingAlpha $GLMD - Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q3 2019 Results - Earnings Call Transcript. Sign up… https://t.co/74Lstwfc5p November 10th 2019, 8:11am |
 |
@AmericanBanking Galmed Pharmaceuticals Ltd $GLMD Receives Average Rating of “Buy” from Analysts https://t.co/gXiRn7pEbK #stocks November 10th 2019, 1:11am |
 |
@ZolmaxNews Galmed Pharmaceuticals Ltd $GLMD Receives Average Rating of “Buy” from Analysts https://t.co/oex2VAh1C9 November 10th 2019, 1:11am |
 |
@OlympiaReport Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Expectations By $0.11 EPS https://t.co/dYYExJGZW7 November 10th 2019, 12:11am |
 |
@WeekHerald Galmed Pharmaceuticals $GLMD Releases Earnings Results https://t.co/zZpDaGn2rA November 10th 2019, 12:11am |
 |
@dispatchtribune Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Expectations By $0.11 EPS https://t.co/1i1EnAeEpo November 10th 2019, 12:11am |
 |
@dakotafinancial Galmed Pharmaceuticals $GLMD Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS https://t.co/D57Swzd2y2 November 10th 2019, 12:11am |
 |
@ThisLincolnian Galmed Pharmaceuticals $GLMD Issues Earnings Results, Beats Estimates By $0.11 EPS https://t.co/K30IMJY1lK November 10th 2019, 12:11am |
 |
@ConsumerFeed Galmed Pharmaceuticals $GLMD Issues Earnings Results, Beats Estimates By $0.11 EPS https://t.co/LFkDOvXY7l November 9th 2019, 11:11pm |
 |
@bbnsnews Galmed Pharmaceuticals $GLMD Announces Quarterly Earnings Results, Beats Expectations By $0.11 EPS https://t.co/0iUHhsOA45 November 9th 2019, 11:11pm |
|
@AmericanBanking Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Estimates By $0.11 EPS https://t.co/yYaZnHgZX2 #stocks November 9th 2019, 7:11pm |
|
@ZolmaxNews Galmed Pharmaceuticals $GLMD Issues Earnings Results https://t.co/TBa7xRnGLE November 9th 2019, 7:11pm |
 |
@dailypoliticaln Galmed Pharmaceuticals $GLMD Posts Earnings Results, Beats Estimates By $0.11 EPS https://t.co/34d8OrReGd November 9th 2019, 7:11pm |
 |
@gcassidy718 $GLMD "Everything is impossible until someone does it" -2.75 % change recently https://t.co/EBd4rufLdZ November 8th 2019, 8:11pm |
 |
@techwhitepapers @Miljenkoz few months ago and yet to be fully disclosed $GLMD has licensed or bought a new mode of action anti infl… https://t.co/UlP68D2ocy November 8th 2019, 11:11am |
|
@techwhitepapers @Miljenkoz as it is $GLMD Aramchol has shown great efficacy in #nash and having twice a day dozing will just make i… https://t.co/lzzJDXwmxV November 8th 2019, 11:11am |
 |
@Miljenkoz @techwhitepapers <to achieve total domination of the #nash space> please, can you expand on that *a-inflammatory drug*? $GLMD November 8th 2019, 11:11am |
|
@techwhitepapers $GLMD has acquired an anti inflammatory drug that will most likely combine with Aramchol to achieve total dominatio… https://t.co/lOQkcO9kfr November 8th 2019, 11:11am |
|
@ConsumerFeed Galmed Pharmaceuticals $GLMD Stock Rating Lowered by ValuEngine https://t.co/P2ihteyMEr November 8th 2019, 1:11am |
|
@bbnsnews Galmed Pharmaceuticals $GLMD Stock Rating Lowered by ValuEngine https://t.co/2o3uUckvnq November 8th 2019, 1:11am |
|
@AmericanBanking Maxim Group Reiterates Buy Rating for Galmed Pharmaceuticals $GLMD https://t.co/0VcOybq4Fi #stocks November 7th 2019, 4:11pm |
 |
@EnterpriseLeade Galmed Pharmaceuticals’ $GLMD “Buy” Rating Reaffirmed at Maxim Group https://t.co/KJfc1tHn8l November 7th 2019, 4:11pm |
|
@dispatchtribune Galmed Pharmaceuticals’ $GLMD “Buy” Rating Reaffirmed at Maxim Group https://t.co/YM3xaYsalc November 7th 2019, 4:11pm |
 |
@SwingTradeBot Fell Below 50 DMA today: $GTX $GLMD ... https://t.co/j2lcQOTpfA November 6th 2019, 2:11pm |
 |
@StockNewsNow $GLMD Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results https://t.co/h1lhZpRKkq November 6th 2019, 11:11am |
|
@Miljenkoz $GLMD Again they wrote bullshit in their Q-ly report! November 6th 2019, 10:11am |
 |
@Stock_News_Now $GLMD: New SEC Filing for GLMD: Form 6-K (No. 0001104659-19-060261): https://t.co/IsPh62Afle November 6th 2019, 7:11am |
 |
@StockTexts $GLMD Galmed Pharmaceuticals Ltd. SEC Filing: Form 6-K https://t.co/Wjj0oeygkQ November 6th 2019, 7:11am |
 |
@otcdynamics $GLMD Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results https://t.co/XQEedyDOza November 6th 2019, 7:11am |
 |
@newsfilterio Galmed EPS beats by $0.09 $GLMD https://t.co/u41r4st3Ah November 6th 2019, 7:11am |
 |
@MarketCurrents $GLMD - Galmed EPS beats by $0.09 https://t.co/9y3V3kvUET November 6th 2019, 7:11am |
 |
@TheMarketsDaily Galmed Pharmaceuticals $GLMD Scheduled to Post Earnings on Wednesday https://t.co/Jr0QlhiccP November 5th 2019, 2:11pm |
 |
@stocknewstimes Galmed Pharmaceuticals $GLMD Scheduled to Post Earnings on Wednesday https://t.co/7EMmBrc8LQ November 5th 2019, 2:11pm |
 |
@WatchlistN Analysts’ Weekly Ratings Changes for Galmed Pharmaceuticals $GLMD https://t.co/UkwKB1vQhV November 4th 2019, 1:11am |
|
@AmericanBanking Analysts’ Weekly Ratings Changes for Galmed Pharmaceuticals $GLMD https://t.co/qPkGE1R7hh #stocks November 4th 2019, 1:11am |
 |
@TickerReport Analysts’ Weekly Ratings Changes for Galmed Pharmaceuticals $GLMD https://t.co/fWauo1IfQE November 4th 2019, 1:11am |
|
@gcassidy718 $GLMD Enjoy the weekend everyone! Cheers! ???? 9.09 % change recently https://t.co/EBd4rufLdZ November 3rd 2019, 12:11pm |
|
@BlueBioNow $GLMD blockbuster 9.09 % change recently https://t.co/NBRHpPSfCE November 2nd 2019, 2:11pm |
|
@TickerReport Galmed Pharmaceuticals $GLMD Shares Up 13% https://t.co/gIaa4lyj8e November 2nd 2019, 12:11pm |
|
@dailypoliticaln Galmed Pharmaceuticals $GLMD Shares Up 13% https://t.co/cFXjzF8413 November 2nd 2019, 12:11pm |
|
@TickerReport Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research https://t.co/ZzDEd5TVGT November 2nd 2019, 11:11am |
|
@dailypoliticaln Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research https://t.co/l2DWvmouyC November 2nd 2019, 11:11am |
|
@TheMarketsDaily Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research https://t.co/azTA7fihyO November 2nd 2019, 10:11am |
|
@dispatchtribune Galmed Pharmaceuticals $GLMD Downgraded by Zacks Investment Research https://t.co/Fp29umrg2F November 2nd 2019, 10:11am |
|
@ZolmaxNews Galmed Pharmaceuticals Ltd $GLMD Sees Significant Growth in Short Interest https://t.co/rhcimjIn1k November 2nd 2019, 4:11am |
|
@Miljenkoz @techwhitepapers They need to clarify P3/4, and what is going on! $GLMD November 1st 2019, 1:11pm |
|
@techwhitepapers @Miljenkoz there are many more reasons than even the ones given. there are many things $glmd is doing these days . November 1st 2019, 11:11am |
|
@Miljenkoz I am not complaining about recent $GLMD move, but please, can someone explain rationale? November 1st 2019, 11:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.